Search

8835 results for: ‘CONTACT COLASHIP.SHOP TO ’

  • Our accreditations

    The University of Leicester School of Business is proud of its numerous accreditations and membership of professional bodies.

  • Attenborough Arts Centre announces new Advisory Board members

    Attenborough Arts Centre today announces the appointment of six new Advisory Board members, following a public recruitment process.

  • Latest Professorial Inaugural Lectures explore cardiovascular research

    Academics from the University's Department of Cardiovascular Sciences will discuss their research in the latest Professorial Inaugural Lectures taking place on Tuesday 2 May.

  • Jonathan Barratt

    The academic profile of Professor Jonathan Barratt, The Mayer Professor of Renal Medicine at University of Leicester

  • Medicine and biosciences

    We collaborate with health professionals locally, nationally and internationally in our pursuit of excellence in biomedical research. We engage in a broad spectrum of biomedical science.

  • Leicester cancer researchers recognised for exceptional contribution

    Two researchers from the University of Leicester have been recognised by the Royal College of Radiologists for their ‘exceptional contribution’ to the field of cancer research.

  • Leicester Professor wins East Midlands Womens Award

    Professor Turi King (pictured) has been awarded the East Midlands Women’s Awards for Outstanding Woman in Stem at a prestigious ceremony on 20 October 2017.

  • Ray Fairbend

    We have learned, with sadness, of the death of Ray Fairbend on 18 September 2024, aged 71.

  • Big wins for Leicester on Varsity Night

    Leicester preserved their unbeaten record in the women's match with a 53-0 victory, while their men also came out on top with a 34-0 win in front of a big and vocal Varsity Night crowd. Playing at No 8 was Sports President and ULWRFC 1st XV Captain Ofure Ugiagbe.

  • Leicester strikes partnership with biotech experts Isogenica to develop personalised cancer treatments

    Patients could benefit from bespoke cancer-fighting treatments with fewer side effects thanks to a new partnership between a biotech company and a UK university.

Back to top
MENU